GSK Says Pfizer Infringed Five Patents Relating to Comirnaty COVID Vaccine
IP Watchdog
APRIL 29, 2024
GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District of Delaware late last week seeking damages for Pfizer and BioNTech’s infringing manufacture, use, sale and marketing of both the original “monovalent” and “bivalent” Comirnaty COVID-19 vaccines.
Let's personalize your content